Healthcare-associated infection in hematopoietic stem cell transplantation patients: Risk factors and impact on outcome

International Journal of Infectious Diseases

Volumn 16, Issue 6, 2012, Pages

  Mendes, Elisa Teixeira ^a   Dulley, Frederico ^a   Basso, Mariusa ^a   Batista, Marjorie Vieira ^a   Coracin, Fabio ^a   Guimarães, Thais ^a   Shikanai Yasuda, Maria Aparecida ^a   Levin, Anna Sara ^a   Costa, Silvia Figueiredo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Healthcare associated infection; Hematopoietic stem cell transplant infection

Indexed keywords

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGE; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BACTEREMIA; BLOODSTREAM INFECTION; BRAZIL; CHILD; COHORT ANALYSIS; DISEASE DURATION; FEMALE; FEVER; GRAM NEGATIVE INFECTION; GRAM POSITIVE INFECTION; HEALTHCARE ASSOCIATED INFECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALIZATION; HUMAN; INVASIVE ASPERGILLOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUCOSA INFLAMMATION; MYCOSIS; NEUTROPENIA; PRESCHOOL CHILD; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; BACTEREMIA; BRAZIL; CHILD; CHILD, PRESCHOOL; FEMALE; FEVER; FUNGEMIA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; NEUTROPENIA; ODDS RATIO; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84860381430     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2012.01.015     Document Type: Article

References (27)

1. Tomblyn M., Chiller T., Einsele H., Gress R., Sepkowitz K., Storek J., et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. ASBMT. Bone Marrow Transplant 2009, 44:453-455.
2. Copelan E.A. Hematopoietic stem-cell transplantation. N Engl J Med 2006, 354:1813-1822.
3. Dettenkofer M., Wenzler-Röttele S., Babikir R., Bertz H., Ebner W., Meyer E., et al. Surveillance of nosocomial sepsis and pneumonia in patients with a bone or peripheral blood stem cell transplant: a multicenter project. Clin Infect Dis 2005, 40:926-931.
4. Nusair A., Jourdan D., Medcalf S., Marion N., Iwen P.C., Fey P.D., et al. Infection control experience in a cooperative care center for transplant patients. Infect Control Hosp Epidemiol 2008, 29:424-429.
5. Schlesinger A., Pau M., Gafter-Gvili A., Rubinovitch B., Leibovici L. Infection-control interventions for cancer patients after chemotherapy: a systematic review and meta-analysis. Lancet Infect Dis 2009, 9:97-107.
6. Kruger W., Russmann B., Kroger N., Salomon C., Ekopf N., Elsner H.A., et al. Early infections in patients undergoing bone marrow or blood stem cell transplantation. A seven year single centre investigation of 409 cases. Bone Marrow Transplant 1999, 23:589-597.
7. Engelhart S., Glasmacher A., Exner M., Kramer M.H. Surveillance for nosocomial infections and fever of unknown origin among adult hematology-oncology patients. Infect Control Hosp Epidemiol 2003, 23:244-248.
8. Dettenkofer M., Ebner W., Bertz H., Babikir R., Finke J., Frank U., et al. Surveillance of nosocomial infections in adult recipients of allogeneic and autologous bone marrow and peripheral blood stem-cell transplantation. Bone Marrow Transplant 2003, 31:795-801.
9. Laws H.J., Kobbe G., Dilloo D., Dettenkofer M., Meisel R., Geisel R., et al. Surveillance of nosocomial infections in paediatric recipients of bone marrow or peripheral blood stem cell transplantation during neutropenia, compared with adult recipients. J Hosp Infect 2006, 62:80-88.
10. von Lilienfeld-Toal M., Lehmann L.E., Raadts A.D., Hahn-Ast C., Orlopp K.S., Marklein G., et al. Utility of a commercially available multiplex real-time PCR assay to detect bacterial and fungal pathogens in febrile neutropenia. J Clin Microbiol 2009, 47:2405-2410.
11. Ley B.E., Linton C.J., Bennett D.M., Jalal H., Foot A.B., Millar M.R. Detection of bacteraemia in patients with fever and neutropenia using 16S rRNA gene amplification by polymerase chain reaction. Eur J Clin Microbiol Infect Dis 1998, 17:247-253.
12. Engels E.A., Ellis C.A., Supran S.E., Schmid C.H., Barza M., Schenkein D.P., et al. Early infection in bone marrow transplantation: quantitative study of clinical factors that affect risk. Clin Infect Dis 1999, 28:256-266.
13. Klastersky J. Concept of empiric therapy with antibiotic combinations: indications and limits. Am J Med 1986, 80:2-12.
14. Ramphal R. Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens. Clin Infect Dis 2004, 39:25-31.
15. Gudiol C. Changing epidemiology, clinical features, and outcomes of bloodstream infection (BSI) in neutropenic cancer patients (NCP). K960. 50th Interscience Conference on Antimicrobial Agents and Chemotherapy, Boston, MA, 2010.
16. Kara O. Changing epidemiology with emerging resistance of bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies. K959. 50th Interscience Conference on Antimicrobial Agents and Chemotherapy, Boston, MA, 2010.
17. Maschmeyer G., Braveny I. Review of the incidence and prognosis of Pseudomonas aeruginosa infections in cancer patients in the 1990s. Eur J Clin Microbiol Infect Dis 2000, 19:915-925.
18. Oliveira A.L., Souza M., Carvalho-Dias V.M., Ruiz M.A., Silla L., Tanaka Y., et al. Epidemiology of bacteremia and factors associated with multidrug-resistant Gram-negative bacteremia in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2007, 39:775-781.
19. Paez J., Levin A.S., Fu L., Basso M., Fonseca G.H., Dulley F.L., et al. Clusters of infection due to metallo-β-lactamase-producing Pseudomonas aeruginosa in stem cell transplant and haematology units. J Hosp Infect 2011, 77:76-92.
20. Marena C., Zecca M., Carenini M.L., Bruschi A., Bassi M.L., Olivieri P., et al. Incidence of, and risk factors for, nosocomial infections among hematopoietic stem cell transplantation recipients with impact on procedure-related mortality. Infect Control Hosp Epidemiol 1999, 22:510-515.
21. Carlisle P.S., Gucalp R., Wiernik P.H. Nosocomial infections in neutropenic cancer patients. Infect Control Hosp Epidemiol 1993, 14:320-332.
22. Toscano C.M., Bell M., Zukerman C., Shelton W., Novicki T.J., Nichols W.G., et al. Gram-negative bloodstream infections in hematopoietic stem cell transplant patients: the roles of needleless device use, bathing practices, and catheter care. Am J Infect Control 2009, 37:327-334.
23. Chaberny I.F., Ruseva E., Sohr D., Buchholz S., Ganser A., Mattner F., et al. Surveillance with successful reduction of central line-associated bloodstream infections among neutropenic patients with hematologic or oncologic malignancies. Ann Hematol 2009, 88:907-912.
24. Litzow M.R., Tarima S., Pérez W.S., Bolwell B.J., Cairo M.S., Camitta B.M., et al. Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood 2010, 115:1850-1857.
25. Campos I.R. Risk factors for invasive fungal infections in haematopoietic stem cell transplantation. Int J Antimicrob Agents 2008, 32:119-123.
26. Marr K.A., Carter R.A., Boeckh M., Martin P., Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002, 100:4358-4366.
27. Cordonnier C., Ribaud P., Herbrecht R., Milpied N., Valteau-Couanet D., Morgan C., et al. Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers. Clin Infect Dis 2006, 42:955-963.